Yukito Ichinose Selected Research

Yukito Ichinose Research Topics

Disease

76	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2019 - 04/2002
29	Neoplasms (Cancer) 06/2018 - 04/2002
18	Adenocarcinoma 01/2018 - 04/2004
17	Lung Neoplasms (Lung Cancer) 05/2019 - 05/2002
9	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2015 - 09/2002
7	Malignant Mesothelioma 06/2018 - 05/2004
6	Diarrhea 05/2019 - 11/2006
6	Neoplasm Metastasis (Metastasis) 04/2018 - 02/2003
5	Febrile Neutropenia 05/2019 - 11/2006
5	Neutropenia 05/2019 - 11/2006
5	Disease Progression 10/2014 - 04/2006
4	Thymoma (Thymic Carcinoma) 04/2016 - 01/2006
4	Adenocarcinoma of Lung 05/2014 - 08/2005
3	Lymphatic Metastasis 04/2018 - 02/2004
3	Leukopenia 01/2017 - 07/2010
3	Lymphoma (Lymphomas) 08/2015 - 01/2010
3	Exanthema (Rash) 09/2013 - 09/2009
3	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2011 - 06/2008
2	Pleural Effusion (Pleural Effusions) 12/2017 - 03/2014
2	Carcinogenesis 09/2016 - 09/2013
2	Infections 01/2016 - 11/2006
2	Acne Vulgaris 09/2013 - 09/2009
2	Drug-Related Side Effects and Adverse Reactions 07/2008 - 11/2005
2	Residual Neoplasm 10/2007 - 04/2002
2	Adenoid Cystic Carcinoma (Cylindroma) 02/2006 - 04/2002
2	Pleurisy (Pleuritis) 06/2004 - 04/2002
1	Small Cell Carcinoma 01/2018
1	Weight Loss (Weight Reduction) 11/2017
1	Hypertension (High Blood Pressure) 11/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Malignant Pleural Effusion 06/2015
1	Adenosquamous Carcinoma 02/2014
1	Disseminated Intravascular Coagulation 11/2013

Drug/Important Bio-Agent (IBA)

30	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 04/2002
19	ErbB Receptors (EGF Receptor)IBA 05/2019 - 06/2005
17	Gefitinib (Iressa)FDA Link 05/2019 - 06/2005
10	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 02/2008
9	PlatinumIBA 05/2019 - 06/2008
9	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 02/2008
9	TegafurIBA 11/2013 - 12/2003
8	Gemcitabine FDA Link 01/2018 - 08/2005
8	Tyrosine Kinase InhibitorsIBA 01/2017 - 10/2005
7	Docetaxel (Taxotere)FDA Link 05/2019 - 09/2002
7	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018 - 08/2005
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 09/2002
6	UracilIBA 06/2008 - 12/2003
5	Bevacizumab (Avastin)FDA Link 05/2019 - 06/2012
5	Pemetrexed (MTA)FDA Link 01/2019 - 05/2008
5	S-1 plus cisplatinIBA 01/2018 - 12/2004
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2017 - 02/2010
4	Anaplastic Lymphoma KinaseIBA 12/2017 - 09/2013
4	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 08/2015 - 01/2010
4	Phosphotransferases (Kinase)IBA 08/2015 - 07/2006
4	amrubicinIBA 04/2014 - 01/2006
4	Vindesine (Vindesin)IBA 02/2008 - 02/2003
3	CrizotinibIBA 01/2017 - 11/2013
3	Carcinoembryonic AntigenIBA 01/2016 - 06/2005
3	Fluorouracil (Carac)FDA LinkGeneric 11/2013 - 06/2006
3	potassium oxonateIBA 05/2010 - 12/2004
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2005 - 06/2005
2	AfatinibIBA 04/2018 - 09/2013
2	130-nm albumin-bound paclitaxelIBA 01/2018 - 07/2013
2	motesanib diphosphateIBA 11/2017 - 08/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 12/2004
2	ceritinibIBA 12/2015 - 07/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2012 - 07/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 09/2011
2	Topotecan (Hycamtin)FDA LinkGeneric 10/2011 - 02/2011
2	titanium silicide (TS-1)IBA 08/2010 - 04/2006
2	Hemoglobins (Hemoglobin)IBA 06/2010 - 05/2008
2	Etoposide (VP 16)FDA LinkGeneric 11/2006 - 05/2005
1	C-Reactive ProteinIBA 06/2018
1	AlbuminsIBA 06/2018
1	alpha-galactosylceramideIBA 01/2017
1	EnzymesIBA 09/2016
1	Anti-Infective Agents (Microbicides)IBA 04/2016
1	Meropenem (Merrem)FDA LinkGeneric 04/2016
1	Cefepime (Maxipime)FDA LinkGeneric 04/2016
1	Sunitinib (Sutent)FDA Link 04/2016
1	Imatinib Mesylate (Gleevec)FDA Link 04/2016
1	Estrogen ReceptorsIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	alectinibIBA 12/2015
1	Epidermal Growth Factor (EGF)IBA 07/2014
1	Topoisomerase II InhibitorsIBA 04/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2014
1	ProdrugsIBA 11/2013

Therapy/Procedure

35	Drug Therapy (Chemotherapy) 05/2019 - 02/2004
20	Therapeutics 05/2019 - 02/2003
16	Radiotherapy 01/2018 - 04/2002
13	Chemoradiotherapy 03/2019 - 09/2002
10	Adjuvant Chemotherapy 01/2017 - 02/2004
8	Combination Drug Therapy (Combination Chemotherapy) 05/2019 - 12/2003
6	Pneumonectomy (Lung Volume Reduction) 03/2019 - 05/2004
3	Thoracotomy 08/2005 - 04/2002
2	Immunotherapy 01/2017 - 08/2013
1	Lymph Node Excision (Lymph Node Dissection) 12/2017
1	Molecular Targeted Therapy 04/2016
1	Metastasectomy 01/2016
1	Segmental Mastectomy (Lumpectomy) 02/2014